CG Oncology Inc. Common stock (CGON) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CG Oncology Inc. Common s...

    NASDAQ: CGON · Real-Time Price · USD
    39.82
    -0.03 (-0.09%)
    At close: Oct 03, 2025, 3:59 PM
    39.82
    0.00%
    Pre-market: Oct 06, 2025, 04:15 AM EDT

    CG Oncology Common stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
    Revenue
    		 n/a 52K 456K 43K 111K 529K 1K 9K n/a 194K n/a
    Cost of Revenue
    		 156K n/a n/a n/a 7K 4K 4K -7.83M 4K 7.84M 4K
    Gross Profit
    		 -156K 52K 456K 43K 111K 525K -3K 9K -4K -7.65M -4K
    Operating Income
    		 -48.74M -42.2M -38.05M -28.3M -25.85M -22.47M -18.93M -14.47M -12.33M -9.72M -9.31M
    Interest Income
    		 7.32M 7.75M 6.25M 7.89M 6.94M 5.55M 2.82M 2.28M 771K 1.05M n/a
    Pretax Income
    		 -41.43M -34.45M -31.8M -20.41M -18.9M -16.93M -16.12M -12.21M -11.61M -8.67M -8.39M
    Net Income
    		 n/a -34.45M -31.8M -20.41M -18.9M -16.93M -16.12M -12.21M -11.61M -8.67M -8.39M
    Selling & General & Admin
    		 17.41M 14.79M 11.71M 8.72M 7.49M 5.78M 3.01M 2.31M 2.49M 2.07M 1.65M
    Research & Development
    		 31.33M 27.47M 26.8M 19.62M 18.47M 17.21M 15.91M 12.16M 9.83M 7.84M 7.66M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a -58K 8K 13K
    Operating Expenses
    		 48.74M 42.26M 38.51M 28.34M 25.96M 22.99M 18.93M 14.47M 12.32M 9.91M 9.31M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a -4K -4K n/a -4K n/a -4K
    Cost & Expenses
    		 48.74M 42.26M 38.51M 28.34M 25.96M 23M 18.93M 14.47M 12.33M 9.91M 9.31M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 76.23M 76.19M 64.82M 67.14M 66.65M 66.64M 66.64M 66.64M 66.64M 66.64M 66.64M
    Shares Outstanding (Diluted)
    		 76.23M 76.19M 64.82M 67.14M 66.65M 66.64M 66.64M 66.64M 66.64M 66.64M 66.64M
    EPS (Basic)
    		 -0.54 -0.45 -0.49 -0.3 -0.28 -0.25 -0.33 -0.28 -0.17 -0.13 -0.13
    EPS (Diluted)
    		 -0.54 -0.45 -0.49 -0.3 -0.28 -0.22 -0.33 -0.28 -0.17 -0.13 -0.13
    EBITDA
    		 -48.74M -42.18M -38.05M -28.27M -25.85M -22.46M -18.93M -14.46M -12.32M -9.72M -9.31M
    EBIT
    		 -41.43M -42.2M -38.05M -28.3M -25.85M -22.47M -18.93M -14.47M -12.33M -9.72M -9.51M
    Depreciation & Amortization
    		 n/a 24K -32K 21K 7K 4K 4K 5K 4K 4K 4K

    Add to Watchlist